Tuberculosis (BCG) vaccine 2027-2029 (2029-2030, 2030-2031)

Helsinki, Suomi | Markkinaoikeus
Julkaistu 4 viikkoa sitten | 5.10.2026 Alkuperäinen ilmoitus

We did procure this: The Ministry of Social Affairs and Health (later referred to as ”STM”) and the Finnish Institute for Health and Welfare (later referred to as "THL" or “Customer” ) request your tender for Tuberculosis (BCG) vaccine, required for vaccinating children under 7 years of age who belong to risk groups as part of the National Immunisation Program in Finland.

The contract period is two (2) years during 2027-2029. The procurement contains two (2) one (1)-year contract period renewals (1 + 1) to extend the contract for the periods 2029-2030 and 2030-2031.

Estimated quantity for the contract period including contract period renewals is 92,000 doses. Customer reserves the right to increase or decrease the ordered numbers of doses by up to 20%.

The contract will be awarded to one Supplier based on a comparison of tenders. Tender that is economically the most advantageous will win the competition. The most economically advantageous Tender shall be a Tender with lowest price.

Please note that all times given in the Call for Tender refer to local time in Finland.

Call for Tenders, annexes:

Annex 1 Contract
Annex 2 JYSE 2025 SUPPLIES
Annex 3 Delivery schedule
Annex 4 Subcontractors
Annex 5 Description of the Handi Service
Annex 6 Bank details
Annex 7 Quality Agreement

Ilmoitusnumero 686671-2026
Ilmoitusta kuvaavat CPV-Koodit Farmaseuttiset tuotteet (33600000), Systeemisesti vaikuttavat infektiolääkkeet, rokotteet sekä syöpälääkkeet ja immunomodulantit (33650000), Rokotteet (33651600)
EUVL S 193/2026
Ilmoitustyyppi Ilmoitus tehdystä sopimuksesta
Aluekoodi
Osoitetiedot Markkinaoikeus
Helsinki
markkinaoikeus@oikeus.fi
https://ted.europa.eu/en/notice/-/detail/686671-2026
Osoite, johon tarjoukset tai osallistumispyynnöt on lähetettävä
Liitteet
Lähde TED